AI-bio’s credit wars: cofounders, IP ownership, and model risk
What Changed and Why It Matters Founders are hitting an IP wall. As AI moves into biotech and R&D-heavy startups, teams are learning the hard way that AI outputs often…
What Changed and Why It Matters Founders are hitting an IP wall. As AI moves into biotech and R&D-heavy startups, teams are learning the hard way that AI outputs often…
What Changed and Why It Matters AI is getting a new layer: an immune system. Not a model. An enforcement and trust layer that keeps models useful in the messy…
What Changed and Why It Matters Robotics and automation just crossed from promise to pull. Multiple signals across capital markets, chips, and factory floors now point in the same direction.…